✨ Free AI Report
Sinovac Biotech Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Sinovac Biotech Ltd.
Company Research

Sinovac Biotech Ltd.: Business Overview, Financials & Competitive Analysis

Sinovac Biotech Ltd. is a China-based global biopharmaceutical company focused on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's vaccine portfol...

Analyst-debate audio for Sinovac Biotech Ltd.

AskCyborg analysts argue the bull and bear cases for Sinovac Biotech Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Mixed

Cyborg Score thesis

Sinovac is a vaccine-focused biotech with established products but faces regulatory compliance risks and governance uncertainties...

Read the full analyst-debate transcript →
Industry Vaccines
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Sinovac Biotech Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Sinovac Biotech Ltd. Overview

Pro stress-test →

Sinovac Biotech Ltd. is a China-based global biopharmaceutical company focused on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's vaccine portfolio includes CoronaVac® for COVID-19 and Healive® for hepatitis, among other products.

Strategic Profile

Pro stress-test →

Sinovac positions itself as a leading provider of biopharmaceutical products in China. The company has faced significant operational challenges, including compliance issues with Nasdaq filing requirements in 2025, triggering a delisting determination in November 2025. However, as of June 2026, the company has regained Nasdaq compliance after filing required annual and interim financial reports.

Competitive Landscape

Pro stress-test →

Sinovac competes in the global vaccine market against major manufacturers including state-sponsored Chinese vaccine producers and international pharmaceutical firms. The company's primary market focus is China and emerging markets in Asia, Africa, and Latin America, where it competes on cost-effectiveness and government procurement relationships.

Industry Context

Sinovac Biotech Ltd. operates in Vaccines.

Key facts

Founded: 1999 · Headquarters: Beijing, China · Employees: 4,281 · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Sinovac Biotech Ltd..

  • Company regained full Nasdaq compliance in June 2026 after filing 2025 annual report and meeting periodic filing requirements.
  • Remains under mandatory Nasdaq panel monitoring through May 2027, indicating conditional compliance status.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2026Regained compliance with Nasdaq Global Market listing requirements after meeting filing obligations.
  • May 2026Filed annual report on Form 20-F for year ended December 31, 2025.
  • +1 moreTrack every material event for Sinovac Biotech Ltd. as it happens. Explore monitoring →
Get alerted when Sinovac Biotech Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Sinovac Biotech Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Sinovac Biotech Ltd. operates in Vaccines. See how the rest of the sector scores on the Cyborg framework.

Browse Vaccines research →
NEW · MCP server

Ask your AI assistant about Sinovac Biotech Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Sinovac Biotech Ltd. and its top competitor on Cyborg Score”
“What did Sinovac Biotech Ltd. do this quarter?”
“Is Sinovac Biotech Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Sinovac Biotech Ltd. do?+
Sinovac Biotech Ltd. is a China-based global biopharmaceutical company focused on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's vaccine portfol...
What is Sinovac Biotech Ltd.'s Cyborg Score?+
Sinovac Biotech Ltd. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Sinovac Biotech Ltd.'s main competitors?+
Named competitors include Sinopharm, Pfizer-BioNTech, Moderna. The full competitive landscape is in the AskCyborg report.
How can I get the full Sinovac Biotech Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Sinovac Biotech Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Sinovac Biotech Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual